Company profile
Prescient Therapeutics
A clinical stage oncology company developing personalised medicine approaches to cancer; cellular & targeted therapies.
- Industry
- Biotechnology Research
- Employees
- 13
- Headquarters
- Melbourne, Victoria
- Founded
- 2014
- LinkedIn followers
- 3,804
- Office locations
- 1
Prescient Therapeutics company summary
Prescient Therapeutics is a company in the Biotechnology Research industry, headquartered in Melbourne, Victoria, founded in 2014. On LinkedIn the company has around 13 employees and 3,804 followers.
What technology does Prescient Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About Prescient Therapeutics
Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: Prescient’s first in class targeted therapy – PTX-100 – is currently in clinical development and showing encouraging activity in diseases of unmet need. Cell therapies: Prescient owns the exclusive rights to two next-generation cell therapy platform technologies, OmniCAR and CellPryme – both with the potential to enhance CAR-T therapies and overcome challenges faced by current generation approaches
Where is Prescient Therapeutics located?
Prescient Therapeutics lists 1 location.
Compare companies similar to Prescient Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
Prescient Therapeutics ptxtherapeutics.com | Biotechnology Research | 13 | 2014 | Melbourne, Victoria |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about Prescient Therapeutics
What does Prescient Therapeutics do?
Prescient Therapeutics (ASX:PTX) is a clinical-stage biotech company developing personalised medicine approaches to cancer, including targeted and cellular therapies. Prescient’s technologies emanate from prestigious world class centres including Yale, Penn, Oxford and Moffitt. Targeted therapy: Prescient’s first in class targeted therapy – PTX-100 – is currently in clinical development and showing encouraging activity in diseases of unmet need. Cell therapies: Prescient owns the exclusive rights to two next-generation cell therapy platform technologies, OmniCAR and CellPryme – both with the potential to enhance CAR-T therapies and overcome challenges faced by current generation approaches
How many employees does Prescient Therapeutics have?
Prescient Therapeutics has around 13 employees on LinkedIn.
Where is Prescient Therapeutics headquartered?
Prescient Therapeutics is headquartered in Melbourne, Victoria.
When was Prescient Therapeutics founded?
Prescient Therapeutics was founded in 2014.
Build a lead list from companies like Prescient Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.